Physician profile
Ryan L Basquez
NPI 1417488826
$271.07
in general payments reported to CMS, 2019-2025
9 companies · $35.88 in 2025
The $35.88 reported for 2025 was less than what a typical Hospice and Palliative Medicine (Internal Medicine) provider received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.00 · 2022: $95.11 · 2023: $50.07 · 2024: $60.01 · 2025: $35.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $92.37 | 2022-2024 | Xarelto |
| Pfizer INC. | $41.83 | 2023-2024 | |
| Merz North America, INC. | $30.00 | 2020 | |
| United Therapeutics Corporation | $26.44 | 2022 | |
| Kestra Medical Technology Services, INC. | $19.71 | 2025 | Assure Wcd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.95 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $16.17 | 2025 | |
| Merck Sharp & Dohme LLC | $14.43 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Basquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.